Abstract:Background: Slow-flow vascular malformations (SFVM) are associated with localized intravascular coagulopathy (LIC), which is characterized by elevated D-dimer and, when severe, hypofibrinogenemia. LIC results in intralesional clotting and hemorrhage and increases risk for significant thrombotic and bleeding complications. Sclerotherapy has been a suggested potential trigger for LIC worsening to disseminated intravascular coagulopathy. Hematologic complications of sclerotherapy in SFVM, along with low-molecular-weight heparin (LMWH) used to prevent worsening LIC, are largely unstudied. Procedure: Medical records of patients with SFVM and LIC who underwent sclerotherapy at Cincinnati Children's Hospital Medical Center from July 2008 to December 2016 were reviewed for periprocedural hematologic complications. LMWH dose, frequency, and course length were evaluated. Results: Fifty-nine patients with SFVM and LIC underwent 281 sclerotherapy procedures, of which 86% were in children. Eighty-five percent of patients received periprocedural LMWH, although at various doses and course lengths. No thrombotic complications occurred in children. One adult on LMWH developed pulmonary emboli after sclerotherapy. No major bleeding complications occurred postoperatively. In four patients, fibrinogen dropped below 100 mg/dL post-sclerotherapy, requiring cryoprecipitate. One patient required packed red blood cell (RBC) transfusion for sclerotherapy-induced hemolysis. No intraoperative bleeding or thrombotic events occurred. Conclusion: LMWH use, at subtherapeutic dosing, was common in this patient population and did not appear to increase risk of significant bleeding before, during, or after sclerotherapy. In children with SFVM, bleeding and thrombotic complications after sclerotherapy appear rare. Although safe, prospective studies are needed to evaluate the efficacy of LMWH to prevent worsening coagulopathy with procedures.

Abstract No. 584 Percutaneous Sclerotherapy of Lymphatic Malformations: Outcomes at a Tertiary Care Pediatric Center

Proven Protocol of Embolization and Sclerotherapy for Venous Malformation of Perineum

Surgery versus sclerotherapy versus combined therapy in head and neck lymphatic malformations in the pediatric population: systematic review and meta-analysis

Sclerothrapy of giant lymphatic malformation in neonates

Simulated Angiography Using a Bleomycin Mixture for Sclerotherapy of Lymphatic Malformations

Abstract No. 583 Percutaneous Cholecystostomy in the Pediatric Patient: A Single-Center Experience

Percutaneous Sclerotherapy of Large Venous Malformations Using Consecutive Polidocanol and Bleomycin Foam: MR Imaging Volumetric and Quality-of-Life Assessment

Efficacy of Bleomycin-Lauromacrogol Foam in Pediatric Macrocystic Lymphatic Malformations With and Without Intracapsular Hemorrhage

Retrospective study of hematologic complications in patients with slow-flow vascular malformations undergoing sclerotherapy

Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations

Lymphatic Malformations: Review of Diagnosis and Management for the Interventional Radiologist

Clinical outcomes and predictors of bleomycin polidocanol foam sclerotherapy treatment response in venous malformations

Primary LYmphedema Multidisciplinary Approach in Patients Affected by Primary Lower Extremity Lymphedema

Selective Lymphatic Duct Embolization for Treatment of Thoracic Lymphatic Flow Disorders in Children: Technical Aspects and Comparison with Thoracic Duct Embolization

Percutaneous treatment of lumbar synovial cysts with bleomycin: A case report

Regional lymph node evaluation in pediatric conventional melanoma subtype: a single-center 10-year review

Sclerotherapy of the Post renal Transplant Lymphoceles: A Meta-Analysis

Experience in the Treatment of Lymphatic Vascular Malformations with Sirolimus, A Prospective Cohort Study in a Tertiary Hospital

Outcome of bleomycin electrosclerotherapy of slow-flow malformations in adults and children

Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations

Laparoscopic partial splenectomy: indications and results of a multicenter retrospective study